Discontinued — last reported Q3 '25
E2609 and BAN2401 — Expense reflected within statements of income
Biogen E2609 and BAN2401 — Expense reflected within statements of income increased by 7.3% to $88.30M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 7.3%, from $82.30M to $88.30M. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
How to read this metric
An increase directly reduces reported operating income, reflecting the company's share of the financial burden for the collaborative development program.
Detailed definition
This metric represents the portion of collaborative development expenses that are recognized as operating costs on the c...
Peer comparison
Comparable to the 'share of loss from equity method investments' or 'collaborative R&D expense' line items found in the income statements of biotech firms with co-development agreements.
biib_segment_e2609_and_ban2401_expense_reflected_within_statements_of_incomeHistorical Data
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $31.10M | $59.20M | $38.50M | $39.30M | $54.70M | $54.00M | $43.00M | $81.70M | $10.90M | $86.90M | $68.90M | $82.30M | $88.30M |
| QoQ Change | — | +90.4% | -35.0% | +2.1% | +39.2% | -1.3% | -20.4% | +90.0% | -86.7% | +697.2% | -20.7% | +19.4% | +7.3% |
| YoY Change | — | — | — | +26.4% | -7.6% | +40.3% | +9.4% | +49.4% | — | +60.9% | +60.2% | +0.7% | +7.3% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Biogen's e2609 and ban2401 — expense reflected within statements of income?
- Biogen (BIIB) reported e2609 and ban2401 — expense reflected within statements of income of $88.30M in Q3 2025.
- How has Biogen's e2609 and ban2401 — expense reflected within statements of income changed year-over-year?
- Biogen's e2609 and ban2401 — expense reflected within statements of income increased by 7.3% year-over-year, from $82.30M to $88.30M.
- What does e2609 and ban2401 — expense reflected within statements of income mean?
- The portion of shared development costs that the company records as an expense on its income statement.